High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
A looming share unlock, a top executive's $52 million stock sale, and stretched valuations are colliding at once for SpaceX, and the next few sessions will test whether buyers hold the line or step aside.
ARK Invest poured about $25.1 million into Rocket Lab while selling roughly $5.8 million of Alphabet shares in its latest disclosed trades
A steep sell-off could turn Rocket Lab into a compelling buy.
SpaceX's historic IPO cratered by nearly a third, yet 28 Wall Street analysts refuse to downgrade it. The question is whether the bull case rests on transformative compounding or on contracts that expire in 90 days.
According to TheFly, Cantor reiterated its $122 target on RKLB as Rocket Lab advances the Iridium transaction and racks up another successful Electron launch.
Rocket Lab (RKLB) just completed another successful Synspective launch, maintained a 100% mission record with that customer, booked 15 more flights through 2030, and continued to advance work on its Neutron rocket and IMM Apex solar technology. For context, Rocket Lab’s recent run of launches and the IMM Apex announcement comes after a choppy stretch in the market, with the share price down 11.02% over 30 days and 32.12% over 90 days, yet supported by a 1-year total shareholder return of...
The flight would be Rocket Lab’s fourth in 25 days and its 18th launch of 2026.
Rocket Lab takes a hit as $1.94 billion stock sale fuels dilution worries
Space stocks are tumbling together on Friday, and the name with no connection to Rocket Lab's pending Iridium deal is somehow leading the group lower, which raises a bigger question about what is actually driving the selloff.
Rocket Lab (RKLB) stock fell 39% between mid-June and September 10, while the S&P 500 gained 2.4%. The stock fell 39%—about twice as far as L3Harris Technologies, down 18.9%, and far more than Lockheed Martin, down 1.3%, and Northrop Grumman, down 5.3%—suggesting company-specific headwinds compounded broader sector softness. Yet the company just posted record revenue, and the CEO counts more than $1 billion of new contracts since Q2 2026 began. None of that changed the Neutron rocket's calendar.
Raymond James said Rocket Lab is building a vertically integrated and capital-efficient space platform, with strong revenue and backlog growth potential.
A multi-billion-dollar insider unlock window just opened at the newly public space giant, and the shockwave is spreading across the entire sector. Here is what the next few trading sessions will reveal about whether insiders plan to cash out or hold their ground.
Rocket Lab (RKLB) trades near $64, about 57% below the high it set inside the last year, though it is still up 49.5% over twelve months against 19.7% for the S&P 500. The business did not break along the way. What changed is the wait: how long before Neutron flies, and how much cash goes out first.
Rocket Lab sits deep in the red after a rocket test failure spooked investors, yet one top Wall Street analyst just doubled down with a target that implies the stock more than doubles from here. The question is whether the backlog can carry the thesis until the next launch attempt.
The insider's sale comes after the stock experienced an impressive 88% one-year return.
Rocket Lab (NasdaqGS:RKLB) completed its 94th Electron mission, deploying Synspective’s StriX Earth-imaging satellite. The launch maintained a 100% mission success record for Synspective payloads on Electron. Synspective has 16 additional Electron missions booked with Rocket Lab to build out its SAR satellite constellation. This kind of repeat launch demand is one angle on the broader space and AI infrastructure theme. There are other stocks with related exposure worth reviewing through 55...
The Synspective “Owl Around The World” mission is now scheduled to launch no earlier than Sept.1.
The comprehensive launch and space systems provider reported a notable insider sale.
Sale executed under predetermined Rule 10b5-1 trading plan; Klein retains 925,737 shares valued at $62.52 million after transaction.
SpaceX just filed a complaint at the FCC that ties regulatory pressure directly into Rocket Lab's share price through a deal structure few investors have fully mapped out.
Rocket Lab has carved out a growing niche in the defense sector.
Non-discretionary sale executed under a Rule 10b5-1 trading plan to cover tax withholding on vesting RSUs. Klein retains 961,295 shares valued at $65.64 million.
The space systems company reported a notable insider sale after its stock's 54% one-year surge.
CEO Peter Beck said Rocket Lab has “a lot” of undisclosed national-security programs and builds missions that “just cannot fail.”
AST SpaceMobile (NASDAQ:ASTS) stock is down 4% to $59.67 midday Wednesday, while the rest of the space complex is barely budging. Traders are pointing to a Falcon 9 wind-down announcement from SpaceX as the threat to launch-dependent names. The move looks more selective than that. Meanwhile, Rocket Lab (NASDAQ:RKLB) stock is down 0.8% to $66.35, ... AST SpaceMobile Falls 4%, Rocket Lab Holds Steady: Is the Falcon 9 Wind-Down Really Hitting Space Stocks?
Trump just ordered a tenfold surge in U.S. launch activity, yet SpaceX and its peers are selling off hard. The reason why reveals a deeper tension between policy ambition and the hardware milestone that actually moves these stocks.
Rocket Lab is building on its space business and has secured several major defense contracts, providing stability amid its rapid expansion.
A number of stocks fell in the afternoon session after surging oil prices and rising long-term interest rates stoked fears of a slowdown in industry orders.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.